Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104447393B reveals waste recovery for Naphthol AS. Enhances supply chain reliability and reduces manufacturing costs significantly for global buyers.
Patent CN114890908B reveals a catalytic method for gamma-trifluoromethyl amino acids using Togni reagents, offering cost reduction in API manufacturing and scalable production.
Patent CN114085219B details asymmetric hydrogenation for high-purity pharmaceutical intermediates. Offers cost reduction and scalable supply chain solutions for global buyers.
Patent CN112279754B reveals a mild blue-light photocatalytic route for fluorinated sesquiterpenes, offering cost-effective scaling for pharmaceutical intermediates.
Novel enzymatic route for high-purity S-Allyl-L-Cysteine from GSAC. Reduces oxidation risks and improves yield for pharmaceutical applications.
Novel two-step catalytic method for carbazole production offering high yield, purity above 99 percent, and recyclable solvents for industrial scale-up.
Patent CN115043846B details a visible-light catalyzed route for pyrroloindole derivatives, offering scalable manufacturing and cost-effective pharmaceutical intermediate production.
Patent CN102584848B reveals improved disproportionation method. Enhances purity and yield for liquid crystal and pharma intermediates.
Patent CN109369608A reveals a novel one-step Ag2O catalyzed route for high-purity heterocyclic intermediates, offering significant cost reduction in fine chemical manufacturing and enhanced supply chain reliability.
Novel deoxyfluorination process for Azivudine intermediate offering high purity and safety for pharmaceutical supply chains. Enables cost reduction and scalable manufacturing for global buyers.
Patent CN105348167A details a novel methanol-based purification method achieving 99.9% purity. This ensures supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN103373914B reveals a breakthrough in hydroxy acid manufacturing using TS-1 catalysts, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN1044278A details a novel epoxidation route for cis-glycidols using sulfonium ylides, offering improved stereoselectivity and cost efficiency for pharmaceutical intermediate manufacturing.
Patent CN101768141A details a safer solvent-free synthesis route. Achieve high purity and reduced environmental impact for pharmaceutical intermediate supply chains.
Novel gamma-butyrolactone route for 3-hydroxymethyl tetrahydrofuran. High yield, low cost agrochemical intermediate manufacturing process suitable for industrial scale-up.
Patent CN102250077B reveals a mild, scalable route for rivaroxaban intermediates, offering significant cost reduction and supply chain reliability for global API manufacturers.
Patent CN110981719A reveals a novel route for 3-carboxybenzaldehyde using m-tolunitrile. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN101104609B discloses a mild reductive amination route for Solanesyl polyamine derivatives, offering high yields and scalable production for oncology drug discovery.
Patent CN111548317A reveals a novel Efavirenz synthesis using Zinc Chloride, offering significant cost reduction and improved yield for pharmaceutical intermediate manufacturing.
Patent CN116143621A reveals a green boron salt catalytic method for converting benzamides to esters. This technology offers high purity, metal-free synthesis for reliable pharmaceutical intermediate supply chains.